by Jenny Dunne | Mar 14, 2025 | Uncategorized
Atlantic Canada’s bioscience sector continues to grow at an impressive pace, creating jobs and driving innovation across the region. To support this momentum, the Government of Canada is investing in the Emergence Bioscience Business Incubator, a key initiative that...
by Jenny Dunne | Mar 6, 2025 | Uncategorized
Natural Products Canada (NPC) has announced investment of $1.7 million into seven early-stage companies bringing its total to $10.6M in investments in 88 Canadian opportunities. The seven companies are recipients of NPC’s Commercialization Programs and represent...
by Jenny Dunne | Feb 27, 2025 | Uncategorized
The National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) aims to foster and support collaborative industrial research and development (R&D) projects with a high potential for commercialization. This call for proposals is open to...
by Jenny Dunne | Feb 13, 2025 | Uncategorized
Alpha Cognition Inc. (NASDAQ: ACOG) (“Alpha Cognition” (ACI), or the “Company”), a biopharmaceutical company developing novel therapeutics for debilitating neurodegenerative disorders, today announced that the United States Patent and Trademark Office (USPTO) has...
by Jenny Dunne | Dec 12, 2024 | Uncategorized
Galenvs Sciences (Galenvs) is the latest company to join Emergence, Atlantic Canada’s bioscience business incubator which is dedicated to assisting start-ups and growth-stage companies in the commercialization of bioscience-based technologies and services. Galenvs...
by Jenny Dunne | Dec 11, 2024 | Uncategorized
Please join us for a Bio Networking Session, presented by Emergence. This session will feature a presentation by Keiretsu Forum Canada, followed by a short Q&A. What trumps what in the world of investing? A prospective view on the investment climate ahead...
